InvestorsHub Logo
Followers 48
Posts 3935
Boards Moderated 0
Alias Born 01/26/2011

Re: dia76ca post# 100016

Thursday, 10/18/2012 6:02:14 PM

Thursday, October 18, 2012 6:02:14 PM

Post# of 346183
Or at least not until Major discrepancies are found again, IMO. And that's the whole problem. If the company cannot recover the data from a gold standard FDA approved double blinded, placebo controlled multi-center trial HOW IN THE WORLD CAN ANYONE TRUST ANYTHING THE COMPANY EVER SAYS AS IT RELATES TO ANY FUTURE TRIAL EVER?!?!?! I'm not exaggerating. I'm curious how.

If the 2nd line NSCLC issue never gets resolved, this company is going nowhere. No data will be received well by the investment community, IMO. Even amazing pancreatic survival data will be mocked by everyone. Even if the lead investigator comes out and says it's a cure, the public will laugh. Until a partner steps up with a monetary commitment there are no trial results aside from FDA Audited 2nd line NSCLC results that will help the PPS. Anything the company says going forward is just fluff until then. It's sad...it really is. So many careers and so much hard work all screwed by some data mix up. So sad. All, IMO.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News